Overview

Actual Use Trial of Ibuprofen 400 mg

Status:
Completed

Trial end date:
2015-05-01

Target enrollment:

Participant gender:

Summary

This is an open label, multicenter, 30 day study designed to mimic an OTC like environment in which subjects will use the product after making a purchase decision about ibuprofen 400 mg caplets based only on their reading of the Drug Facts Label (DFL) and other information on the package.

Phase:

Phase 3

Details

Lead Sponsor:

Pfizer

Treatments:

Ibuprofen